Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on etanercept therapy in rheumatic diseases
Etanercept is a biologic medication used to treat various rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. It works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By blocking TNF, Etanercept helps reduce inflammation, pain, and joint damage.
In rheumatoid arthritis, Etanercept has shown to significantly improve symptoms and slow disease progression. Patients experience relief from joint stiffness, swelling, and pain, leading to better physical function. It is often prescribed when other treatments, like methotrexate, do not provide sufficient results.
For psoriatic arthritis and ankylosing spondylitis, Etanercept also offers benefits by reducing joint inflammation and preventing further joint damage. It helps improve mobility and overall quality of life. However, long-term use requires regular monitoring, as it can increase the risk of infections and other side effects.
Overall, Etanercept provides an effective treatment option for patients with rheumatic diseases, especially when conventional therapies fall short.
Therefore, get an overall knowledge of etanercept therapy in rheumatic diseases. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation